TMEM59, transmembrane protein 59, 9528

N. diseases: 20; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3809250
Disease: ESTROGEN RESISTANCE
ESTROGEN RESISTANCE
0.100 SusceptibilityMutation disease CLINVAR
CUI: C0017638
Disease: Glioma
Glioma
0.020 Biomarker disease BEFREE Dendritic cell-derived factor 1 (Dcf1) is known to play an important role in neural stem cell differentiation, glioma apoptosis, dendritic spine formation, and Alzheimer's disease (AD), nevertheless, the involvement of the <i>Dcf1</i> gene in the brain immune response has not yet been reported. 30104955 2018
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.020 Biomarker group BEFREE Such alteration derails the intracellular trafficking of TMEM59 and the xenophagic response against bacterial infection. 27541200 2016
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.020 AlteredExpression group BEFREE Such alteration impairs the unconventional autophagic activity of TMEM59, a transmembrane protein that contains the WD40 domain-binding motif, and disrupts its normal intracellular trafficking and its ability to engage ATG16L1 in response to bacterial infection. 27273576 2016
CUI: C0017638
Disease: Glioma
Glioma
0.020 AlteredExpression disease BEFREE Overexpression of DCF1 inhibits glioma through destruction of mitochondria and activation of apoptosis pathway. 24424470 2014
CUI: C0003467
Disease: Anxiety
Anxiety
0.010 Biomarker disease BEFREE Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors. 31531752 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.010 Biomarker group BEFREE Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors. 31531752 2019
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 Biomarker disease BEFREE All the results indicated that DCF1 could be a potential therapeutic target for the understanding and treatment of NB. 30365123 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.010 Biomarker disease BEFREE All the results indicated that DCF1 could be a potential therapeutic target for the understanding and treatment of NB. 30365123 2019
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.010 Biomarker disease BEFREE All the results indicated that DCF1 could be a potential therapeutic target for the understanding and treatment of NB. 30365123 2019
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE Dendritic cell-derived factor 1 (Dcf1) is known to play an important role in neural stem cell differentiation, glioma apoptosis, dendritic spine formation, and Alzheimer's disease (AD), nevertheless, the involvement of the <i>Dcf1</i> gene in the brain immune response has not yet been reported. 30104955 2018
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 Biomarker disease BEFREE In conclusion, these findings suggest that the TAT-DCF1 fusion protein was efficiently transduced into Glioblastoma U251 cells and induced the antitumor effect and support further investigation into specific targeting and side effects of TAT-DCF1 during drug delivery. 30001801 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.010 Biomarker disease BEFREE Our findings revealed an important role of DCF1 in PD process and may provide new potential strategies for developing drugs to treat neurodegenerative diseases. 29649746 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 Biomarker disease BEFREE In conclusion, these findings suggest that the TAT-DCF1 fusion protein was efficiently transduced into Glioblastoma U251 cells and induced the antitumor effect and support further investigation into specific targeting and side effects of TAT-DCF1 during drug delivery. 30001801 2018
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.010 Biomarker disease BEFREE In conclusion, these findings suggest that the TAT-DCF1 fusion protein was efficiently transduced into Glioblastoma U251 cells and induced the antitumor effect and support further investigation into specific targeting and side effects of TAT-DCF1 during drug delivery. 30001801 2018
CUI: C0524851
Disease: Neurodegenerative Disorders
Neurodegenerative Disorders
0.010 Biomarker group BEFREE Our findings revealed an important role of DCF1 in PD process and may provide new potential strategies for developing drugs to treat neurodegenerative diseases. 29649746 2018
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.010 Biomarker disease BEFREE In conclusion, these findings suggest that the TAT-DCF1 fusion protein was efficiently transduced into Glioblastoma U251 cells and induced the antitumor effect and support further investigation into specific targeting and side effects of TAT-DCF1 during drug delivery. 30001801 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE Dendritic cell factor 1 plays important roles in neural stem cells differentiation and in glioma cells proliferation, migration, and invasion. 26025395 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 AlteredExpression group BEFREE The present study identified a previously unknown cancer apoptosis mechanism involving dcf1 overexpression and provided a novel approach to potentially treat glioma patients. 24424470 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 AlteredExpression group BEFREE The present study identified a previously unknown cancer apoptosis mechanism involving dcf1 overexpression and provided a novel approach to potentially treat glioma patients. 24424470 2014
CUI: C1318973
Disease: Staphylococcus aureus infection
Staphylococcus aureus infection
0.010 Biomarker disease BEFREE Endogenous TMEM59 interacts with ATG16L1 and mediates autophagy in response to Staphylococcus aureus infection. 23376921 2013
CUI: C0494463
Disease: Alzheimer Disease, Late Onset
Alzheimer Disease, Late Onset
0.010 Biomarker disease BEFREE The TMEM59 gene identified from our discovery approach was recently implicated in amyloid-β protein precursor post-translational processing, supporting a role for epigenetic change in LOAD pathology. 22451312 2012